“Woah! It's like Spotify but for academic articles.”

Instant Access to Thousands of Journals for just $30/month

On Gestagen Treatment of Advanced Prostatic Carcinoma

On Gestagen Treatment of Advanced Prostatic Carcinoma Depostat® treatment was found to reduce plasma testosterone and to have a gonadotrophin suppressive effect in males. In our study the clinical effect on prostatic cancer was, however, disappointing when compared to the well established effect of orchiectomy. The therapeutic failure of Depostat® might be related to the incomplete suppression of plasma testosterone compared to that observed after orchiectomy. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Scandinavian Journal of Urology and Nephrology Informa Healthcare

On Gestagen Treatment of Advanced Prostatic Carcinoma

Abstract

Depostat® treatment was found to reduce plasma testosterone and to have a gonadotrophin suppressive effect in males. In our study the clinical effect on prostatic cancer was, however, disappointing when compared to the well established effect of orchiectomy. The therapeutic failure of Depostat® might be related to the incomplete suppression of plasma testosterone compared to that observed after orchiectomy.
Loading next page...
 
/lp/informa-healthcare/on-gestagen-treatment-of-advanced-prostatic-carcinoma-9riFTaxNYu

Sorry, we don't have permission to share this article on DeepDyve,
but here are related articles that you can start reading right now: